Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Novo Nordisk Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Novo Nordisk Canada Inc.

arrow
ChemOutsourcing
Not Confirmed

Novo Nordisk Canada Inc.

Country
arrow
ChemOutsourcing
Not Confirmed

SOMAPACITAN

Brand Name : SOGROYA

Patent Number : 2787890

Filing Date : 2011-01-24

Strength per Unit : 5mg / 1.5mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-24

Date Granted : 2020-01-14

blank

02

Novo Nordisk Canada Inc.

arrow
ChemOutsourcing
Not Confirmed

Novo Nordisk Canada Inc.

Country
arrow
ChemOutsourcing
Not Confirmed

SOMAPACITAN

Brand Name : SOGROYA

Patent Number : 2787890

Filing Date : 2011-01-24

Strength per Unit : 10mg / 1.5mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-24

Date Granted : 2020-01-14

blank

03

Novo Nordisk Canada Inc.

arrow
ChemOutsourcing
Not Confirmed

Novo Nordisk Canada Inc.

Country
arrow
ChemOutsourcing
Not Confirmed

SOMAPACITAN

Brand Name : SOGROYA

Patent Number : 2787890

Filing Date : 2011-01-24

Strength per Unit : 15mg / 1.5mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-24

Date Granted : 2020-01-14

blank